These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30467840)

  • 21. Irreversibly sickled erythrocytes in sickle cell anemia: a quantitative reappraisal.
    Rodgers GP; Noguchi CT; Schechter AN
    Am J Hematol; 1985 Sep; 20(1):17-23. PubMed ID: 4025318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease.
    Gupta P; Kumar R
    Nitric Oxide; 2024 Mar; 144():40-46. PubMed ID: 38316197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
    Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying Shear-Induced Deformation and Detachment of Individual Adherent Sickle Red Blood Cells.
    Deng Y; Papageorgiou DP; Chang HY; Abidi SZ; Li X; Dao M; Karniadakis GE
    Biophys J; 2019 Jan; 116(2):360-371. PubMed ID: 30612714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte deformability in sickle-cell crisis.
    Kenny MW; Meakin M; Worthington DJ; Stuart J
    Br J Haematol; 1981 Sep; 49(1):103-9. PubMed ID: 7272221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The irreversibly sickled cell.
    Smith CM; Krivit W; White JG
    Am J Pediatr Hematol Oncol; 1982; 4(3):307-15. PubMed ID: 7149169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia.
    Sandor B; Marin M; Lapoumeroulie C; Rabaï M; Lefevre SD; Lemonne N; El Nemer W; Mozar A; Français O; Le Pioufle B; Connes P; Le Van Kim C
    Br J Haematol; 2016 Apr; 173(1):145-9. PubMed ID: 26846309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transgenic mouse model of sickle cell disorder.
    Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F
    Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal neutrophil adhesion in sickle cell anaemia and crisis: relationship to blood rheology.
    Boghossian SH; Nash G; Dormandy J; Bevan DH
    Br J Haematol; 1991 Jul; 78(3):437-41. PubMed ID: 1873228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients.
    Sakamoto TM; Lanaro C; Ozelo MC; Garrido VT; Olalla-Saad ST; Conran N; Costa FF
    Microvasc Res; 2013 Nov; 90():173-9. PubMed ID: 24144783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal rheology of oxygenated blood in sickle cell anemia.
    Chien S; Usami S; Bertles JF
    J Clin Invest; 1970 Apr; 49(4):623-34. PubMed ID: 5443167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte adhesion in sickle cell disease.
    Parise LV; Telen MJ
    Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis.
    Akinola NO; Stevens SM; Franklin IM; Nash GB; Stuart J
    Br J Haematol; 1992 Aug; 81(4):598-602. PubMed ID: 1390248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis.
    Ojuawo A; Adedoyin MA; Fagbule D
    Cent Afr J Med; 1994 Dec; 40(12):342-5. PubMed ID: 7882414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheological effects of bed rest in sickle cell disease.
    Keidan AJ; Stuart J
    J Clin Pathol; 1987 Oct; 40(10):1187-8. PubMed ID: 3680542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle-cell anemia.
    Stuart MJ; Stockman JA; Oski FA
    J Pediatr; 1974 Nov; 85(5):629-32. PubMed ID: 4423856
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of irreversibly sickled cells in reducing the osmotic fragility of red cells in sickle cell anemia.
    Figueiredo MS; Zago MA
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):49-56. PubMed ID: 2932889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion.
    Mehta P; Mehta J
    Stroke; 1979; 10(4):464-6. PubMed ID: 505486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion.
    Setty BN; Chen D; O'Neal P; Littrell JB; Grossman MH; Stuart MJ
    J Lab Clin Med; 1998 Apr; 131(4):344-53. PubMed ID: 9579388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microfluidic approach to study the effect of mechanical stress on erythrocytes in sickle cell disease.
    Lizarralde Iragorri MA; El Hoss S; Brousse V; Lefevre SD; Dussiot M; Xu T; Ferreira AR; Lamarre Y; Silva Pinto AC; Kashima S; Lapouméroulie C; Covas DT; Le Van Kim C; Colin Y; Elion J; Français O; Le Pioufle B; El Nemer W
    Lab Chip; 2018 Sep; 18(19):2975-2984. PubMed ID: 30168832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.